Features
Tips for Removing Foreign Bodies
Consider using the inferior port when removing IOFBs from the posterior segment.
By James C. Rice, FCOphth (SA), Jason Thomas, FCOphth (SA), Jonel Steffen, FCOphth (SA), et al.
A Roundtable on Complexities in Retinal Surgery
In Retinal Physician’s annual panel discussion, leading surgeons share challenging cases and evaluate their management.
By Christina Y. Weng, MD, MBA, John B. Miller, MD, Raymond Iezzi Jr, MD, et al.
In Research, Diversity Matters
Misleading assumptions reduce Black and Hispanic or Latino representation in clinical trials.
By Jeremiah Brown, MD, FASRS, Stephen Huddleston, MD, Kapil G. Kapoor, MD, FACS, FICS, FASRS
Robotic System Tested in Retinal Surgery
The first-in-human trial of the Luca system suggests robotic surgery may be safe and feasible.
By Jim Gallagher, senior managing editor
Scleral Buckling for Phakic Rhegmatogenous Retinal Detachment
Retinal surgeons are revisiting a time-tested technique in the modern era.
By Luis A. Acabá-Berrocal, MD, Maria H. Berrocal, MD
Web Exclusives
Bringing Retina Surgery Into the Office
A firsthand look at how a practice transitioned to office-based surgery for urgent and elective cases.
By Jonathan Feistmann, MD
Departments
Surgery, Science, and Inclusion
Upfront: This issue features articles on equitable research, complex surgical procedures, and treatment updates.
By Diana V. Do, MD
How Harrow Brought Triesence Back to Market
Retina Conversations: A conversation with Amir H. Shojaei, PharmD, PhD, Harrow’s chief scientific officer.
By Jim Gallagher, senior managing editor
An Update on Local Steroids for Uveitis
Uveitis Corner: As Retisert exits and Triesence returns, uveitis care enters a new phase.
By Sruthi Arepalli, MD
Navigating Retina Surgery Coding
Coding Q&A: Understand bundling rules and documentation requirements to ensure accurate billing.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
News
Systemic Complement Activation Linked to Progression of Intermediate AMD
“The classical pathway should receive more attention in the study of AMD pathogenesis,” the study researchers found.
By Sarah Fackler, staff writer
Study Explores Cannabis Use and PVR Risk
Following retinal detachment repair, cannabis users demonstrated lower rates of postoperative prolierative vitreoretinopathy compared to controls.
By Sarah Fackler, staff writer
Study Reveals Promising Drug Target in Uveal Melanoma
A landmark CRISPR–Cas9 screening study identified synthetic lethality between CDS1 and CDS2 for various tumor types.
By Sarah Fackler, staff writer